Cipher Pharmaceuticals Inc.
CPHRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.47 | 0.08 | -0.94 | 0.02 |
| FCF Yield | 3.78% | 2.53% | 1.85% | 3.46% |
| EV / EBITDA | 42.41 | 37.09 | 57.31 | 167.09 |
| Quality | ||||
| ROIC | 3.91% | 3.40% | 1.69% | -1.51% |
| Gross Margin | 81.70% | 81.33% | 76.05% | 56.61% |
| Cash Conversion Ratio | 1.96 | 1.02 | 1.61 | 2.66 |
| Growth | ||||
| Revenue 3-Year CAGR | 33.26% | 33.79% | 25.18% | 17.26% |
| Free Cash Flow Growth | 77.36% | 42.72% | -52.49% | 347.93% |
| Safety | ||||
| Net Debt / EBITDA | 0.73 | 2.08 | 4.31 | 13.61 |
| Interest Coverage | 20.87 | 14.23 | 5.28 | 3.49 |
| Efficiency | ||||
| Inventory Turnover | 0.35 | 0.45 | 0.52 | 0.89 |
| Cash Conversion Cycle | 169.98 | 106.12 | 95.54 | 104.09 |